Home › Waldenstrom Macroglobulinemia › Ohio › Columbus
Waldenstrom Macroglobulinemia clinical trials in Columbus, OH
5 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RecruitingPhase 1
- The Ohio State University, Columbus
A Long-term Extension Study of PCI-32765 (Ibrutinib)
RecruitingPhase 3
- The Ohio State University- James Cancer Hospital, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RecruitingPhase 1
- Ohio State University, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Edison, NJ6 studies
- Houston, TX6 studies
- Seattle, WA5 studies
- Rochester, MN5 studies
- Milwaukee, WI5 studies
- Queens, NY4 studies
- Baldwin Park, CA4 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer27 studies
- Endometrial Cancer26 studies
- Colorectal Cancer24 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.